Recent Patents on Space Technology
Title:Patent Selections:
Volume: 3 Issue: 1
Export Options
About this article
Cite this article as:
Patent Selections:, Recent Patents on Space Technology 2013; 3 (1) . https://dx.doi.org/10.2174/1877611611303010010
DOI https://dx.doi.org/10.2174/1877611611303010010 |
Print ISSN 2210-6871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1877-6116 |
18
Related Articles
-
Hydroxy Cinnamic Acid Derivatives as Partial PPARγ Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562)
Anti-Cancer Agents in Medicinal Chemistry Mitochondrial Permeability Transition as Target of Anticancer Drugs
Current Pharmaceutical Design Polyploidy: The Link Between Senescence and Cancer
Current Pharmaceutical Design Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
Current Drug Targets Atopic Dermatitis in the Elderly
Inflammation & Allergy - Drug Targets (Discontinued) New Aspects of Cyclosporin A Mode of Action: from Gene Silencing to Gene Up-Regulation
Mini-Reviews in Medicinal Chemistry The Expression Patterns and Clinical Significance of microRNAs in Liver Diseases and Hepatocellular Carcinoma
Current Pharmaceutical Design Insights in microRNAs Biology
Current Topics in Medicinal Chemistry Induction of Apoptotic Cell Death in Tumor Cells by S100A8/A9 Released from Inflammatory Cells Upon Cellular Activation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Delivery of Personalised, Precision Medicines <i>via</i> Synthetic Proteins
Drug Delivery Letters The Challenge of a “Functional Cure” for AIDS by Gene Modified HSCT Therapy
Current Stem Cell Research & Therapy Biosystems Engineering of Prokaryotes with Tumor-Killing Capacities
Current Pharmaceutical Design Current Technological Development of Antibody Therapeutics
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Dual Inhibitors of PI3K/mTOR or mTOR-Selective Inhibitors: Which Way Shall We Go?
Current Medicinal Chemistry The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
Current Drug Targets The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
Current Molecular Medicine Preface [Hot topic: Histone Deacetylase Inhibitors (Guest Editor: Kristof Van Emelen)]
Current Medicinal Chemistry CEBP Epigenetic Dysregulation as a Drug Target for the Treatment of Hematologic and Gynecologic Malignancies
Current Drug Targets Fyn Kinase in Brain Diseases and Cancer: The Search for Inhibitors
Current Medicinal Chemistry γ δ T Cells and Dendritic Cells: Close Partners and Biological Adjuvants for New Therapies
Current Molecular Medicine